索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]王擎 王建礼 王海英 王志农 苑金香.糖尿病对心房颤动的作用[J].国际心血管病杂志,2020,01:40-43.
点击复制

糖尿病对心房颤动的作用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2020年01期
页码:
40-43
栏目:
综述
出版日期:
2020-01-14

文章信息/Info

Title:
-
作者:
王擎 王建礼 王海英 王志农 苑金香
272113济宁医学院(王擎,王建礼,王海英,苑金香); 200000上海,海军军医大学第二附属医院胸心外科(王志农)
Author(s):
-
关键词:
糖尿病;  心房纤颤;  心房重构;  治疗靶点
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2020.01.010
文献标识码:
-
摘要:
糖尿病是心房颤动(房颤)发生的主要危险因素之一。在糖尿病状态下,自主神经重构、电重构、电机械重构、结构重构是引起房颤的主要病理生理机制。该文阐述糖尿病与房颤的密切联系,讨论其主要的病理生理机制,并针对糖尿病引起的心房重构提出可能的上游治疗靶点。
Abstract:
-

参考文献/References

[ 1 ]Ball J, Carrington MJ, Mcmurray JJ, et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century[J]. Int J Cardiol, 2013, 167(5):1807-1824.
[ 2 ]Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study[J]. JAMA, 1994, 271(11):840-844.
[ 3 ]Huxley RR, Filion KB, Konety S, et al. Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation[J]. Am J Cardiol, 2011, 108(1):56-62.
[ 4 ]Dahlqvist S, Rosengren A, Gudbjornsdottir S, et al. Risk of atrial fibrillation in People with type 1 diabetes compared with matched controls from the general population:a prospective case-control study[J]. Lancet Diabetes Endocrinol, 2017, 5(10):799-807.
[ 5 ]Du X, Ninomiya T, De Galan B, et al. Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation:results of the ADVANCE study[J]. Eur Heart J, 2009, 30(9):1128-1135.
[ 6 ]Movahed MR, Hashemzadeh M, Jamal MM. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease[J]. Int J Cardiol, 2005, 105(3):315-318.
[ 7 ]Pfister R, Michels G, Cairns R, et al. Incidence of new onset bundle branch block and atrial fibrillation in patients with type 2 diabetes and macrovascular disease: an analysis of the PROactive study[J]. Int J Cardiol, 2011, 153(2):233-234.
[ 8 ]Aksnes T, Schmieder RE, Kjeldsen SE, et al. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension(from the VALUE trial)[J]. Am J Cardiol, 2008, 101(5):634-638.
[ 9 ]Ostgren CJ, Merlo J, Råstam L, et al. Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community[J]. Diabetes Obes Metab, 2004, 6(5):367-374.
[10]Huxley RR, Alonso A, Lopez FL, et al. Type 2 diabetes,glucose homeostasis and incident atrial fibrillation: the atherosclerosis risk in communities study[J]. Heart, 2012, 98(2):133-138.
[11]Sun G, Ma M, Ye N, et al. Diabetes mellitus is an independent risk factor for atrial fibrillation in a general Chinese population[J]. J Diabetes Investig, 2016, 7(5):791-796.
[12]Urbancic-Rovan V, Meglict B, Stefanovska A, et al. Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in Type 2 diabetic patients[J]. Diabet Med, 2007, 24(1):18-26.
[13]Otake H, Suzuki H, Honda T, et al. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart[J]. Int Heart J, 2009, 50(5):627-641.
[14]Heijman J, Voigt N, Nattel S, et al. Cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance, and progression[J]. Circ Res, 2014, 114(9):1483-1499.
[15]Watanabe M, Yokoshiki H, Mitsuyama H, et al. Conduction and refractory disorders in the diabetic atrium[J]. Am J Physiol Heart Circ Physiol, 2012, 303(1):H86-H95.
[16]Liu C, Fu H, Li J, et al. Hyperglycemia aggravates atrial interstitial fibrosis, Ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits[J]. Anadolu Kardiyol Derg, 2012, 12(7):543-550.
[17]Fu H, Liu C, Li J, et al. Impaired atrial electromechanical function and atrial fibrillation promotion in alloxan-induced diabetic rabbits[J]. Cardiol J, 2013, 20(1):59-67.
[18]Ayhan S, Ozturk S, Alcelik A, et al. Atrial conduction time and atrial mechanical function in patients with impaired fasting glucose[J]. J Interv Card Electrophysiol, 2012, 35(3):247-252.
[19]Acar G, Akcay A, Sokmen A, et al. Assessment of atrial electromechanical delay,diastolic functions,and left atrial mechanical functions in patients with type 1 diabetes mellitus[J]. J Am Soc Echocardiogr, 2009, 22(6):732-738.
[20]Akyel A, Oksüz F, Karadeniz M, et al. Atrial electromechanical delay in type 2 diabetes mellitus[J]. Wien Klin Wochenschr, 2014, 126(3/4):101-105.
[21]Kato T, Yamashita T, Sekiguchi A, et al. AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat[J]. J Cardiovasc Electrophysiol, 2008, 19(4):415-420.
[22]Korantzopoulos P, Kolettis TM, Galaris D, et al. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation[J]. Int J Cardiol, 2007, 115(2):135-143.
[23]Rochette L, Zeller M, Cottin Y, et al. Diabetes, oxidative stress and therapeutic strategies[J]. Biochim Biophys Acta, 2014, 1840(9):2709-2729.
[24]Liang X, Zhang Q, Wang X, et al. Reactive Oxygen species mediated oxidative stress links diabetes and atrial fibrillation[J]. Mol Med Rep, 2018, 17(4):4933-4940.
[25]Mitasíková M, Lin H, Soukup T, et al. Diabetes and thyroid hormones affect connexin-43 and PKC-epsilon expression in rat heart atria[J]. Physiological Research, 2009, 58(2):211-217.
[26]Lip GY, Varughese GI. Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links[J]. Int J Cardiol, 2005, 105(3):319-321.
[27]Vardas PE, Vemmos K, Sideris DA, et al. Susceptibility of the right and left canine atria to fibrillation in hyperglycemia and hypoglycemia[J]. J Electrocardiol, 1993, 26(2):147-153.
[28]Saito S, Teshima Y, Fukui A, et al. Glucose fluctuations increase the incidence of atrial fibrillation in diabetic rats[J]. Cardiovasc Res, 2014, 104(1):5-14.
[29]Fontes JD, Lyass A, Massaro JM, et al. Insulin resistance and atrial fibrillation(from the Framingham Heart Study)[J]. Am J Cardiol, 2012, 109(1):87-90.
[30]Chang SH, Wu LS, Chiou MJ, et al. Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies[J]. Cardiovasc Diabetol, 2014, 13:123.
[31]Cariou B, Charbonnel B, Staels B. Thiazolidinediones and PPARγ agonists: time for a reassessment[J]. Trends Endocrinol Metab, 2012, 23(5):205-215.
[32]Chao TF, Leu HB, Huang CC, et al. Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes[J]. Int J Cardiol, 2012, 156(2):199-202.
[33]Gong YT, Li WM, Li Y, et al. Probucol attenuates atrial autonomic remodeling in a canine model of atrial fibrillation produced by prolonged atrial pacing[J]. Chin Med J, 2009, 122(1):74-82.

备注/Memo

备注/Memo:
基金项目:2019年济宁医学院人才引进启动基金
作者单位:272113济宁医学院(王擎,王建礼,王海英,苑金香); 200000上海,海军军医大学第二附属医院胸心外科(王志农)
通信作者:苑金香,E-mail:yuanjinxiang@yahoo.com
更新日期/Last Update: 2020-01-15